Aptamer-Based Immune Drug Systems (AptIDCs) Potentiating Cancer Immunotherapy
Aptamers are artificial oligonucleotides with excellent molecule-targeting ability. Compared with monoclonal antibodies, aptamers have the advantages of low cost, no batch effect, and negligible immunogenicity, making them promising candidates for cancer immunotherapy. To date, a series of aptamer a...
| 出版年: | Chemistry |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
MDPI AG
2023-07-01
|
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2624-8549/5/3/114 |